Rate of appearance of abnormal prothrombin following initiation of oral-anticoagulant treatment.
D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007122:Immunoelectrophoresis; D011516:Prothrombin; D011817:Rabbits; D013997:Time Factors
D000925:Anticoagulants; D011516:Prothrombin